CS Diagnostics Corp. (CSDX)
OTCMKTS
· Delayed Price · Currency is USD
0.150
-0.030 (-16.53%)
Mar 9, 2026, 3:37 PM EST
CS Diagnostics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2009 | FY 2008 | FY 2007 | 2006 - 2002 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2006 - 2002 |
| Cash & Equivalents | 0 | 0 | 0.02 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0 | 0.02 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Cash Growth | -99.94% | -97.54% | -45.52% | -0.01% | -0.27% | 3288.97% | Upgrade
|
| Total Current Assets | 0.03 | 0 | 0.02 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0.02 | 0.02 | 0 | Upgrade
|
| Other Intangible Assets | 499.4 | 499.4 | 499.4 | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | - | - | 0 | Upgrade
|
| Total Assets | 499.43 | 499.4 | 499.42 | 0.06 | 0.06 | 0.04 | Upgrade
|
| Accounts Payable | 0 | 0 | 0.01 | 1.15 | 0.85 | 0.79 | Upgrade
|
| Accrued Expenses | - | - | - | 0.72 | 0.75 | 0.77 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.37 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | - | 0 | Upgrade
|
| Total Current Liabilities | 0 | 0 | 0.01 | 1.87 | 1.6 | 1.93 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 1.03 | Upgrade
|
| Total Liabilities | 0 | 0 | 0.01 | 1.87 | 1.6 | 2.96 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.05 | 0.05 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 504.16 | 504.16 | 504.17 | 4.13 | 4.13 | 2.36 | Upgrade
|
| Retained Earnings | -4.74 | -4.77 | -4.77 | -5.99 | -5.72 | -5.32 | Upgrade
|
| Comprehensive Income & Other | - | -0 | - | - | - | - | Upgrade
|
| Total Common Equity | 499.43 | 499.4 | 499.41 | -1.81 | -1.54 | -2.92 | Upgrade
|
| Shareholders' Equity | 499.43 | 499.4 | 499.41 | -1.81 | -1.54 | -2.92 | Upgrade
|
| Total Liabilities & Equity | 499.43 | 499.4 | 499.42 | 0.06 | 0.06 | 0.04 | Upgrade
|
| Total Debt | - | - | - | - | - | 1.39 | Upgrade
|
| Net Cash (Debt) | 0 | 0 | 0.02 | 0.04 | 0.04 | -1.36 | Upgrade
|
| Net Cash Growth | -99.94% | -97.54% | -45.52% | -0.01% | - | - | Upgrade
|
| Net Cash Per Share | - | - | 0.00 | 0.39 | 0.39 | - | Upgrade
|
| Filing Date Shares Outstanding | 137.34 | 137.34 | 110.79 | 0.1 | 0.1 | - | Upgrade
|
| Total Common Shares Outstanding | 137.34 | 137.29 | 110.79 | 0.1 | 0.1 | - | Upgrade
|
| Working Capital | 0.03 | -0 | 0.01 | -1.84 | -1.57 | -1.9 | Upgrade
|
| Book Value Per Share | 3.64 | 3.64 | 4.51 | -18.79 | -15.99 | - | Upgrade
|
| Tangible Book Value | 0.03 | -0 | 0.01 | -1.81 | -1.54 | -2.92 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | -0.00 | 0.00 | -18.79 | -15.99 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.